Dergiler / Pediatric Practice and Research / 2019 / Cilt: 7 - Sayı: 3

Nöral tüp defekti etkilenen çocuklarda MTHFR enziminin kantitatif değerlendirilmesi

Quantitative Evaluation of MTHFR Enzyme in Neural Tube Defect Affected Children

Sayfa
19–24
Yayın Tarihi
2019-12-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Neural tube defect (NTD) pathogenesis is still not understanding well and controversial.
📊
Temel Bulgular & Veri:Patients and methods: A cohort study was performed during 2017- 2018 in Al- Batool hospital.
💡
Sonuç & Katkı:Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017- 2018 Verileri
⚙️Değişkenler:MTHFR · Neural tube defect · Congenital

Abstract

Background: Neural tube defect (NTD) pathogenesis is still not understanding well and controversial. Maternal Methylene Tetrahydrofolate Reductase (MTHFR) is an important enzyme controlling levels of methionine, homocysteine, and folic acid in the cycle of folate metabolism which has a considerable relationship with NTD development, while the role fetal MTHFR enzyme was not known till now. Objective: To evaluate the serum level of MTHFR in NTDs affected children to search if it is related to the defect pathogenesis. Patients and methods: A cohort study was performed during 2017- 2018 in Al- Batool hospital. A newly delivered NTD affected babies were included, serum level of MTHFR was measured by ELISA, results were compared to that of healthy neonates. SPSS version 22 was used for statistical analysis. Results: Forty six infants with NTD were included, spina bifida (n=39, 84.8%) and cranial NTD (7, 15.2%), females: males ratio was 1:1.35. MTHFR enzyme readings showed wide range in both healthy and NTD affected infants, generally, for cases they were insignificantly higher than that of control group (p value= 0.115); they were unrelated with the defect whether cranial or spinal, p value (0.264 ). Enzyme level significantly higher in NTD affected infants whom mothers aged more 35 yrs old (p value= 0.00) and insignificantly higher in babies whom mothers received folic acid than others. Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.

🔖

Bu Makaleye Atıf Yap

MAHMOOD, N. S. (2019). Nöral tüp defekti etkilenen çocuklarda MTHFR enziminin kantitatif değerlendirilmesi. Pediatric Practice and Research, Cilt: 7 - Sayı: 3, 19–24. https://ajindex.com/articles/795400

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Au K.S., Ashley-Koch A., Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev. Disabil. Res. Rev. 2010;16:6–15. Lynch S.A. Non-multifactorial neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet. 2005;135C:69–76. Blom H.J. Folic acid, methylation and neural tube closure in humans. Birth Defects Res. 2009;85:295–302.
  2. Blom H.J., Shaw G.M., den Heijer M., Finnell R.H. Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 2006;7:724–731.
  3. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011;34:75–81.
  4. De Marco P., Merello E., Cama A., Kibar Z., Capra V. Human neural tube defects: Genetic causes and prevention. Biofactors. 2011;37:261–268. Van der Put N.M., van Straaten H.W., Trijbels F.J., Blom H.J. Folate, homocysteine and neural tube defects: An overview. Exp. Biol. Med. 2001;226:243–270.
  5. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862–877.
  6. Algasham A, Ismail H, Dewaidar M, Settin AA. Methylenetetrahydrofolate reductase and angiotensin-converting enzyme gene polymorphisms among saudi population from qassim region. Genet Test Mol Biomarkers2009;13:817-20.
  7. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp. 1994;181:180- 91. Apolline Imbard, Jean-François Benoist, Henk J. Blom. Neural tube defects, folic acid and methylation. Int J Environ Res Public Health. 2013 Sep; 10(9): 4352–4389.
  8. Van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J ObstetGynecolReprod Biol. 2000;92:57–61. 13. Van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. ExpBiol Med (Maywood) 2001;226:243–270.
  9. Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab. 2000;70:53–60.
  10. Peadar N Kirke, James L Mills, Anne M Molloy, Lawrence C Brody, Valerie B O'Leary, Leslie Daly, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ. 2004 Jun 26; 328(7455): 1535–1536.
  11. Marini NJ, Hoffman